- Home
- AVD vs AMRN Comparison
AVD vs AMRN Comparison
Compare AVD & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVD
- AMRN
- Stock Information
- Founded
- AVD 1969
- AMRN 1989
- Country
- AVD United States
- AMRN Ireland
- Employees
- AVD N/A
- AMRN 275
- Industry
- AVD Agricultural Chemicals
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- AVD Industrials
- AMRN Health Care
- Exchange
- AVD Nasdaq
- AMRN Nasdaq
- Market Cap
- AVD 165.8M
- AMRN 189.2M
- IPO Year
- AVD N/A
- AMRN 1993
- Fundamental
- Price
- AVD $4.38
- AMRN $0.46
- Analyst Decision
- AVD Strong Buy
- AMRN Buy
- Analyst Count
- AVD 3
- AMRN 1
- Target Price
- AVD $16.67
- AMRN N/A
- AVG Volume (30 Days)
- AVD 296.0K
- AMRN 1.7M
- Earning Date
- AVD 11-11-2024
- AMRN 10-30-2024
- Dividend Yield
- AVD 2.03%
- AMRN N/A
- EPS Growth
- AVD N/A
- AMRN N/A
- EPS
- AVD N/A
- AMRN N/A
- Revenue
- AVD $553,839,000.00
- AMRN $241,021,000.00
- Revenue This Year
- AVD N/A
- AMRN N/A
- Revenue Next Year
- AVD $5.31
- AMRN N/A
- P/E Ratio
- AVD N/A
- AMRN N/A
- Revenue Growth
- AVD N/A
- AMRN N/A
- 52 Week Low
- AVD $4.36
- AMRN $0.43
- 52 Week High
- AVD $14.28
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- AVD 25.15
- AMRN 40.30
- Support Level
- AVD $5.91
- AMRN $0.43
- Resistance Level
- AVD $6.29
- AMRN $0.50
- Average True Range (ATR)
- AVD 0.24
- AMRN 0.03
- MACD
- AVD -0.16
- AMRN 0.00
- Stochastic Oscillator
- AVD 5.77
- AMRN 30.00
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.